The immunocytochemical expression of VE-1 (BRAF V600E-related) antibody identifies the aggressive variants of papillary thyroid carcinoma on liquid-based cytology

Maurizio Martini, Celestino Pio Lombardi, Alfredo Pontecorvi, Patrizia Straccia, Chiara Brunelli, Teresa Musarra, Guido Fadda, Esther D Rossi, Paola Lanza

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The recently introduced monoclonal V600E antibody (clone VE1) is likely to be an alternative strategy for detecting this mutation in thyroid lesions. Although VE1 immunostaining and molecular methods used to assess papillary thyroid carcinoma in surgical specimens are in good agreement, evaluation of VE1 in cytology and cell block samples is rarely performed, and its diagnostic value in cytology has not been well established. In this study, we sought to determine if VE1 is suitable for FNA and cell block method.
Original languageEnglish
Pages (from-to)1-23
Number of pages23
JournalCytopathology
DOIs
Publication statusPublished - 2019

Keywords

  • BRAFV600E antibody (clone VE1)
  • PTC
  • Thyroid nodules
  • cell block
  • fine needle aspiration

Fingerprint

Dive into the research topics of 'The immunocytochemical expression of VE-1 (BRAF V600E-related) antibody identifies the aggressive variants of papillary thyroid carcinoma on liquid-based cytology'. Together they form a unique fingerprint.

Cite this